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Galanin was measured by radioimmunoassay in extracts of pig, cat and rat adrenals using non-C- and mid 
to C-terminally directed antibodies. The extracts were fractioned by gel chromatography and HPLC. The 
non-C-terminal galanin immunoreactivity in pig was 92.8 _+ 11.7 pmol/g, in cat 9.1 f 0.9 pmol/g and in rat 
< 1 pmol/g. Two higher molecular forms of galanin have been identified in both pig and cat adrenal. One 
major large form behaves as if it was N-terminally extended (K,, pig 0.58, cat 0.48) and the other, a very 
high-molecular-mass form (K,” pig 0.10, 0.24, cat 0. lo), as if it had both N- and C-terminal extensions. 
Galanin Molecular form Adrenal gland 
1. INTRODUCTION 
Galanin is a newly discovered gastrointestinal 
peptide originally isolated from porcine intestine 
[l]. It contains 29 amino acids and its name is 
derived from the fact that its N- and C-terminal 
residues are glycine and alanine. The amino acid 
sequence of galanin is different from other pep- 
tides and therefore it does not belong to a known 
peptide family. At the C-terminal end of the 
molecule galanin shares four amino acids with 
gonadotropin releasing hormone (GnRH), three 
with physalaemin (Phys, a frog skin peptide) and 
two with substance P (SP, a mammalian neuropep- 
tide) [2]. Galanin shows potent biological actions 
increasing smooth muscle contractility in the 
gastrointestinal and genitourinary tract of several 
species [ 1,3,4] and inhibiting insulin secretion and 
producing hyperglycaemia in dogs [2]. 
So far, galanin immunoreactivity has been 
demonstrated in the central [5-91 and peripheral 
nervous system, in the intestine [5,10,11], 
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respiratory [12] and genitourinary tract [13] of dif- 
ferent mammalian species including man. An 
abstract report states that galanin-like im- 
munoreactivity is present in cells of the adrenal 
medulla [14]. As yet, preliminary chromatographic 
characterisation of galanin immunoreactivity has 
only been reported in the central nervous system 
[5,6] and the gastrointestinal tract [5,15] of several 
mammalian species. 
Here we investigated the localisation and 
molecular heterogeneity of galanin in pig, cat and 
rat adrenal using radioimmunoassay, gel- 
permeation chromatography and reverse-phase 
high performance liquid chromatography 
(HPLC). 
2. MATERIALS AND METHODS 
2.1. Specimens 
Fresh whole adrenals were collected from pigs 
(n = 6), cats (n = 8) and rats (n = 20). The animals 
were killed with an overdose of pentobarbitone 
(pig and cat) or by cervical dislocation (rat). 
Published by Elsevier Science Publishers B. V. (Biomedical Divrsion) 
00145793/86/$3.50 0 1986 Federation of European Biochemical Societies 327 
Volume 201, number 2 FEBS LETTERS June 1986 
2.2. Tissue extraction 
Fresh pre-weighed tissue samples were plunged 
into pre-heated polypropylene tubes containing 
0.5 M acetic acid (approx. 10 ml/g tissue) and 
boiled at 100°C for 15 min in a water bath and 
then cooled and stored at - 20°C until assay. 
2.3. Radioimmunoassay 
Galanin was measured using a specific and sen- 
sitive radioimmunoassay [ 151. The antisera used 
were produced in rabbits immunised with uncon- 
jugated porcine galanin. Two antibodies 
(designated Gal-8 and Gal-9) had sufficient affini- 
ty for assay and were employed at a final dilution 
of l/480000 and l/48000, respectively. For both 
antibodies the assay was capable of detecting 
changes between adjacent tubes of 2 fmol/tube 
with 95% confidence. This corresponds to 
1 pmol/g tissue. There was no cross-reactivity of 
the antibodies with GnRH, Phys, SP, vasoactive 
intestinal polypeptide (VIP) or adrenocor- 
ticotropin hormone (ACTH) in peptide concentra- 
tions up to 10 pmoI/tube. Regional specificity 
studies using a C-terminal galanin IO-29 fragment 
suggested that Gal-8 is non-C- and Gal-9 mid to C- 
terminally directed. Dose response curves of tissue 
extracts of several mammalian species showed 
parallel displacement using both antibodies with 
the exception of the rat [15], The non-parallel 
displacement of rat extracts has been confirmed by 
others [5]. 
The ‘251-1abelled porcine galanin tracer was 
prepared by the modified iodogen method [16] and 
the iodinated peptide purified by HPLC on a 5 pm 
Techsil C-18 column eluted isocratically with 28% 
acetonitrile/0.05% trifluoroacetic acid. The 
specific activity of the label was 72.7 Bq/fmol 
(1.96 mCi/fmol). Galanin tracer (1.5 fmol) and 
galanin antiserum were added to each tube to a 
total volume of 800~1 and tissue extracts (20~1) 
were assayed in duplicate. 
The intra and inter assay variability showed a 
coefficient of variation of 6.0 + 0.3 and 11.2 i 
0.3%, respectively (X -t SE). 
2.4. Gem-permeation chromatography 
Galanin immunoreactivity in adrenal extracts of 
pig (n = 5) and cat (n = 4) were chromatographed 
on a 1.5 x 100 cm column of Sephadex G-50 
superfine (Pharmacia, Uppsala) eluted with 
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0.06 mol/l phosphate buffer, pH 7.4, containing 
7.5 mmolll sodium azide, 0.01 mol/l EDTA and 
0.15 mol/l bovine serum albumin at a flow rate of 
6 ml/h. Fractions of 2.0 ml were collected for 
subsequent radio~mmunoassay. Internal column 
markers run with each sample were dextran blue 
(I’,,), horse heart cytochrome c (CC) and Na’*‘I 
(V,). The elution co-efficient (iu,,) was calculated 
according to Laurent and Killander [17]. The 
recovery of all runs was 80-106%. Standard and 
sample pretreatment using SepPak cartridges did 
not influence the elution position. 
2.5. High performance liquid chromatography 
Tissue extracts of pig (n = 5) and cat (n = 4) 
adrenals and porcine galanin standard were ab- 
sorbed onto SepPak C-IS cartridges (Waters 
Associates, Milford, USA) and eluted with 1.5 ml 
of 60% acetonitrile/0.05% trifluoroacetic acid 
before being loaded for HPLC (Waters Associates) 
on a 5 pm Techsil, C-18 column, 4.6 x 250 mm 
(HPLC Technology, Macclesfield, England). In- 
itially the column was run isocratically at 25% 
acetonitrile for 10 min then a linear gradient was 
developed from 25 to 32% acetonitrile/0.05% 
trifluoroacetic acid over 70 min and from 32 to 
50% over 54 min. The flow rate was 1 ml a min-’ 
and 2 ml fractions were collected. The recovery of 
all runs was 78-104%. 
3. RESULTS 
3.1. Radioimmunoassay 
The adrenal tissue concentration of galanin im- 
munoreactivity in pig, cat and rat are shown in 
table 1. The highest concentrations using the non- 
C-terminal antibody (Gal-8) were found in pig 
(92.8 f: 11.7 pmollg) and cat (9.1 -+ 0.9 pmol/g). 
The C-terminal antibody (Gal-9) only detected 
71.4 k 8.1 pmol/g in the pig and none in the cat. 
Neither antibody detected any galanin-IR in rat 
adrenals (< 1 pmol/g). 
3.2. Chromatography 
Representative gel-permeation chromatographic 
profiles of galanin immunoreactivity in pig and cat 
adrenal are shown in fig.1. No elution profile 
could be demonstrated for rat adrenal extracts. Us- 
ing the non-~-terminally directed antibody (Gal-8) 
porcine adrenals showed four peaks at Kav (peak) 
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Table 1 
Galanin immunoreactivity in pig, cat and rat adrenals 
using an non-C-(Gal 8) and C-(Gal 9) terminal directed 
antibody 
Gal 8 Gal 9 
Pig adrenal (n = 6) 92.8 f 11.7 71.4 + 8.1 
Cat adrenal (n = 8) 9.1 + 0.9 <1 
Rat adrenal (n = 20) <l.O <l 
Results expressed as pmol/g wet wt of tissue (mean + 
SE) 
vo cc Vt 
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Fig. 1. Representative gel-permeation chromatographic 
profiles of pig and cat adrenal extracts on a column 
(1.5 x 100 cm) of Sephadex G-50 superfine using a non- 
C-(Gal-8) (0) and C-(Gal-9) (A) terminal directed 
antibody. Arrows indicate elution position of dextran 
blue (V,), horse heart cytochrome c (CC) and Na’251 
(V,). The pig extracts eluted in four peaks at K,, 0.10, 
0.24, 0.48 and 0.68 (porcine standard position). The cat 
extracts emerged in three peaks at K,, 0.10, 0.48 and 
20-I A 
I 
I I I I I I I I 
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Fig.2. Representative reverse-phase HPLC profiles of 
pig and cat adrenal extracts (Gal-8). In pig galanin 
immunoreactivity eluted in four peaks at retention times 
of 44, 56, 82 and 114 min. In cats galanin eluted also in 
four peaks at retention times of 40, 56, 72 and 124 min. 
The porcine standard emerged in a single peak at 
0.57. 56 min. 
0.10 (l), 0.24 (2), 0.48 (3) and in the position of the 
porcine galanin standard at KaV 0.68 (4). The C- 
terminally directed antibody (Gal-9) did not detect 
peaks 1 and 2 but detected peaks 3 and 4 in an 
equimolar ratio compared to Gal-B. In cat adrenals 
using Gal-g 3 peaks of galanin eluted at Kav (peak) 
0.10 (l), 0.48 (2) and 0.57 (3). In contrast to por- 
cine adrenal, the C-terminal directed antibody 
(Gal-9) did not detect galanin immunoreactivity in 
the cat adrenal. 
Fig.2 shows representative HPLC profiles from 
pig and cat adrenals. Four peaks could be shown 
in both species using Gal-S. In pig adrenal galanin 
eluted at retention times (peak) of 44 (l), 56 (2), 82 
(3) and 114 (4) min. In cat adrenals the retention 
times (peak) were 40 (l), 56 (2), 72 (3) and 124 (4) 
min. The porcine standard emerged in a single 
peak at 56 min. The corresponding peaks of subse- 
quent gel-permeation chromatography of each 
HPLC peak in both species are shown in table 2. 
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Table 2 
Subsequent gel-permeation chromatography of each 
reverse-phase HPLC peak and its corresponding peak of 
galanin immunoreactivity in gel-permeation 
chromatography of adrenal extracts of pig and cat using 
the non-C-terminal antibody galanin 8 
HPLC 
Peak Retention 
no. time 
(min) 
G-50 column 
Peak Kay 
no. 
Pig 1 44 3 0.48 
2 56 4 0.68 
3 82 2 0.24 
4 114 1 0.10 
Cat 1 40 2 0.48 
2 56 2 0.48 
3 72 3 0.57 
4 124 1 0.10 
4. DISCUSSION 
Galanin immunoreactivity has been shown in 
substantial quantities in pig and cat adrenals but in 
rat adrenals the galanin content, as measured by 
these antibodies, was very low. 
Different extraction procedures (0.5 M acetic 
acid, pH 2.77, water, pH 7.0, Tris buffer, pH 8.5) 
for several species howed much greater recoveries 
in acetic acid and no molecular form differences 
could be shown on gel chromatography of extracts 
from the three extraction regimes [Is]. Thus it 
seems unlikely that the molecular pattern is a mere 
artefact of the extraction procedure. 
Using gel chromatography porcine galanin 
eluted in four peaks. The two largest were detected 
only by the non-C-terminal antibody, whereas the 
other two peaks, present in larger amounts, were 
detected by both antibodies. The HPLC elution 
profile also showed four peaks of porcine galanin 
and subsequent gel chromatography of the HPLC 
peaks confirmed each gel chromatographic peak. 
Using the non-C-terminal antibody on gel 
chromatography the cat adrenal extracts eluted in 
three peaks. The C-terminal antibody did not 
detect any galanin in the cat. On HPLC four peaks 
of cat galanin immunoreactivity could be shown. 
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Subsequent gel chromatography of the HPLC 
peaks also confirmed each gel chromatographic 
peak but HPLC peaks one and two eluted on gel 
chromatography at the same position (Kay 0.48). 
The last eluting HPLC peak corresponded to the 
largest size molecular form on gel 
chromatography. 
In both species the results could be explained by 
extensions at the N- and C-terminal end of the dif- 
ferent molecular forms as shown in fig.3. The in- 
ability of the C-terminal antibody to detect the 
porcine G-50 peak 1 and 2 (K,, 0.10 and 0.24, 
respectively) and all cat G-50 peaks indicates the 
possibility of C-terminal extensions of the galanin 
molecule in both species. In cat extracts it would 
also suggest species equence differences compared 
to the porcine standard. In contrast to this the 
detection of porcine G-50 peak 3 (K,” 0.58) by the 
non-C- and C-terminal antibody and cat G-50 peak 
2 flu,, 0.48) only by the non-C-terminal antibody 
suggests an N-terminal extension in both species. 
Furthermore, this finding may indicate that the 
non-C-terminal antibody is N- to mid-terminal 
rather than exclusively N-terminal. The lack of 
cross-reaction of cat galanin with the C-terminal 
antibody wouId also be in accordance with C- 
terminal amino acid differences possibly accom- 
panied by N- and/or C-terminal extensions. 
Thus, two higher-molecular-mass forms of 
galanin have been shown. One major large form, 
apparently extended at the N-terminal end &: 
pig 0.58, cat 0.481, and another very high- 
molecular-mass form (KaV: pig 0.10, 0.24, cat 
O.lO), apparently with N- and C-terminal exten- 
sions. It is possible that the latter is a galanin 
precursor from which the peptide itself is cleaved 
Kav Peak No 
Standard 0.68 I 1 
Pig 0.68 4 I -I 
0.48 3 t I 
0.24 2 r 4 
0.10 1 t----B 
Cat 0.57 3 t. 4 
0.48 2 t I 
0.10 1 I I 
Fig.3. Theoretical scheme of possible muIti-molecular 
form model of gaianin in the pig and cat adrenal. 
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by post-translational processing. However, an ag- 
gregate of galanin or of galanin with other proteins 
cannot be excluded. For VIP and NPY, which are 
also present in the adrenal gland high-molecular- 
mass material has been shown in phaeochromo- 
cytomas [ 18,191 and ganglioneuroblastomas [ 191. 
Further investigations are needed to clarify the 
nature and activity of the high-molecular-mass 
forms of galanin. 
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